Montaner JS - Search Results

1

Characterizing retention in HAART as a recurrent event process: insights into 'cascade churn'.

Nosyk B, Lourenço L, Min JE, Shopin D, Lima VD, Montaner JS; STOP HIVAIDS Study Group. Nosyk B, et al. Among authors: montaner js. AIDS. 2015 Aug 24;29(13):1681-9. doi: 10.1097/QAD.0000000000000746. AIDS. 2015. PMID: 26372279 Free PMC article.

2

Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme.

Wood E, Tyndall MW, Spittal PM, Li K, Hogg RS, Montaner JS, O'Shaughnessy MV, Schechter MT. Wood E, et al. Among authors: montaner js. AIDS. 2002 Apr 12;16(6):941-3. doi: 10.1097/00002030-200204120-00021. AIDS. 2002. PMID: 11919503

3

Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up.

Hogg RS, Heath K, Bangsberg D, Yip B, Press N, O'Shaughnessy MV, Montaner JS. Hogg RS, et al. Among authors: montaner js. AIDS. 2002 May 3;16(7):1051-8. doi: 10.1097/00002030-200205030-00012. AIDS. 2002. PMID: 11953472

4

Prescribing practices in a population-based HIV postexposure prophylaxis program.

Braitstein P, Chan K, Beardsell A, McLeod A, Montaner JS, O'Shaughnessy MV, Hogg RS. Braitstein P, et al. Among authors: montaner js. AIDS. 2002 May 3;16(7):1067-70. doi: 10.1097/00002030-200205030-00014. AIDS. 2002. PMID: 11953474

5

Consecutive rebounds in plasma viral load are associated with virological failure at 52 weeks among HIV-infected patients.

Raboud JM, Rae S, Woods R, Harris M, Montaner JS; INCAS and AVANTI Study Groups. Raboud JM, et al. Among authors: montaner js. AIDS. 2002 Aug 16;16(12):1627-32. doi: 10.1097/00002030-200208160-00008. AIDS. 2002. PMID: 12172084 Clinical Trial.

6

No association between GB virus-C viremia and virological or immunological failure after starting initial antiretroviral therapy.

Brumme ZL, Chan KJ, Dong WW, Mo T, Wynhoven B, Hogg RS, Montaner JS, O'Shaughnessy MV, Harrigan PR. Brumme ZL, et al. Among authors: montaner js. AIDS. 2002 Sep 27;16(14):1929-33. doi: 10.1097/00002030-200209270-00010. AIDS. 2002. PMID: 12351953

7

Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996.

Wood E, Montaner JS, Chan K, Tyndall MW, Schechter MT, Bangsberg D, O'Shaughnessy MV, Hogg RS. Wood E, et al. Among authors: montaner js. AIDS. 2002 Oct 18;16(15):2065-72. doi: 10.1097/00002030-200210180-00012. AIDS. 2002. PMID: 12370506

8

Influence of polymorphisms within the CX3CR1 and MDR-1 genes on initial antiretroviral therapy response.

Brumme ZL, Dong WW, Chan KJ, Hogg RS, Montaner JS, O'Shaughnessy MV, Harrigan PR. Brumme ZL, et al. Among authors: montaner js. AIDS. 2003 Jan 24;17(2):201-8. doi: 10.1097/00002030-200301240-00010. AIDS. 2003. PMID: 12545080

9

Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?

Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JS. Wood E, et al. Among authors: montaner js. AIDS. 2003 Mar 28;17(5):711-20. doi: 10.1097/00002030-200303280-00009. AIDS. 2003. PMID: 12646794

10

Prolonged retention of drug resistance mutations and rapid disease progression in the absence of therapy after primary HIV infection.

Chan KC, Galli RA, Montaner JS, Harrigan PR. Chan KC, et al. Among authors: montaner js. AIDS. 2003 May 23;17(8):1256-8. doi: 10.1097/00002030-200305230-00020. AIDS. 2003. PMID: 12819530

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

843 results

Search Page

Filters